Morphometric post-mortem studies in bipolar disorder: Possible association with oxidative stress and apoptosis

International Journal of Neuropsychopharmacology

Volumn 14, Issue 8, 2011, Pages 1075-1089

  Gigante, Alexandre Duarte ^a,b   Young, Lionel Trevor ^a   Yatham, Lakshmi N ^a   Andreazza, Ana Cristina ^a   Nery, Fabiano Gonãalves ^b   Grinberg, Lea Tenenholz ^c   Heinsen, Helmut ^d   Lafer, Beny ^b  

^a UNIVERSITY OF BRITISH COLUMBIA   (Canada)

^b UNIVERSITY OF SÃO PAULO   (Brazil)

^c UNIVERSITY OF CALIFORNIA   (United States)

^d UNIVERSITY OF WÜRZBURG   (Germany)

Author keywords

Apoptosis; bipolar disorder; neuropathology; oxidative stress

Indexed keywords

AMYGDALOID NUCLEUS; ANTERIOR CINGULATE; APOPTOSIS; BIPOLAR DISORDER; CADAVER; CELL DAMAGE; CELL DEATH; CELL DENSITY; CELL SIZE; FRONTAL CORTEX; GLIA CELL; HIPPOCAMPUS; HUMAN; MORPHOMETRICS; NERVE CELL; NEUROIMAGING; OXIDATIVE STRESS; PREFRONTAL CORTEX; PRIORITY JOURNAL; REVIEW; THALAMUS;

APOPTOSIS; BIPOLAR DISORDER; BRAIN; HUMANS; NEUROGLIA; NEURONS; OXIDATIVE STRESS;

EID: 80052961123     PISSN: 14611457     EISSN: 14695111     Source Type: Journal    
DOI: 10.1017/S146114571000146X     Document Type: Review

References (118)

1. Abdalla DS, Monteiro HP, Oliveira JA, Bechara EJ (1986). Activities of superoxide dismutase and glutathione peroxidase in schizophrenic and manic-depressive patients. Clinical Chemistry 32, 805-807. (Pubitemid 17028354)
2. Aliyazicioglu R, Kural B, Colak M, Karahan SC, et al. (2007). Treatment with lithium, alone or in combination with olanzapine, relieves oxidative stress but increases atherogenic lipids in bipolar disorder. Tohoku Journal of Experimental Medicine 213, 79-87. (Pubitemid 47516904)
3. Altshuler L, Bookheimer S, Townsend J, Proenza MA, et al. (2008). Regional brain changes in bipolar I depression: a functional magnetic resonance imaging study. Bipolar Disorder 10, 708-717.
4. Andreazza AC, Cassini C, Rosa AR, Leite MC, et al. (2007a). Serum S100B and antioxidant enzymes in bipolar patients. Journal of Psychiatric Research 41, 523-529. (Pubitemid 46227446)
5. Andreazza AC, Frey BN, Erdtmann B, Salvador M, et al. (2007b). DNA damage in bipolar disorder. Psychiatry Research 153, 27-32. (Pubitemid 47376945)
6. Andreazza AC, Kapczinski F, Kauer-Sant'Anna M, Walz JC, et al. (2009). 3-Nitrotyrosine and glutathione antioxidant system in patients in the early and late stages of bipolar disorder. Journal of Psychiatry & Neuroscience 34, 263-271.
7. Andreazza AC, Kauer-Sant'anna M, Frey BN, Bond DJ, et al. (2008). Oxidative stress markers in bipolar disorder: a meta-analysis. Journal of Affective Disorders 111, 135-144.
8. Andreazza AC, Shao L, Wang JF, Young LT (2010). Mitochondrial complex I activity and oxidative damage to mitochondrial proteins in the prefrontal cortex of patients with bipolar disorder. Archives of General Psychiatry 67, 360-368.
9. Arnone D, Cavanagh J, Gerber D, Lawrie SM, et al. (2009). Magnetic resonance imaging studies in bipolar disorder and schizophrenia: meta-analysis. British Journal of Psychiatry 195, 194-201.
10. Atmaca M, Yildirim H, Ozdemir H, Poyraz AK, et al. (2006). Hippocampal 1H MRS in first-episode bipolar I patients. Progress in Neuro-psychopharmacology & Biological Psychiatry 30, 1235-1239. (Pubitemid 44216058)
11. Beasley CL, Cotter DR, Everall IP (2002a). Density and distribution of white matter neurons in schizophrenia, bipolar disorder and major depressive disorder: no evidence for abnormalities of neuronal migration. Molecular Psychiatry 7, 564-570.
12. Beasley CL, Zhang ZJ, Patten I, Reynolds GP (2002b). Selective deficits in prefrontal cortical GABAergic neurons in schizophrenia defined by the presence of calcium-binding proteins. Biological Psychiatry 52, 708-715.
13. Bei E, Salpeas V, Pappa D, Anagnostara C, et al. (2009). Phosphorylation status of glucocorticoid receptor, heat shock protein 70, cytochrome c and Bax in lymphocytes of euthymic, depressed and manic bipolar patients. Psychoneuroendocrinology 34, 1162-1175.
14. Benes FM, Kwok EW, Vincent SL, Todtenkopf MS (1998). The reduction of nonpyramidal cells in sector CA2 of schizophrenics and manic-depressives. Biological Psychiatry 44, 88-97. (Pubitemid 28305527)
15. Benes FM, Lange N (2001). Two-dimensional vs. three-dimensional cell counting: a practical perspective. Trends in Neurosciences 24, 11-17. (Pubitemid 32332892)
16. Benes FM, Matzilevich D, Burke RE, Walsh J (2006). The expression of proapoptosis genes is increased in bipolar disorder, but not in schizophrenia. Molecular Psychiatry 11, 241-251.
17. Benes FM, Vincent SL, Todtenkopf M (2001). The density of pyramidal and nonpyramidal neurons in previous cingulate cortex of schizophrenia and bipolar subjects. Biological Psychiatry 50, 395-406. (Pubitemid 32885589)
18. Berretta S, Pantazopoulos H, Lange H (2007). Neuron numbers and volume of the amygdala in subjects diagnosed with bipolar disorder or schizophrenia. Biological Psychiatry 62, 884-893. (Pubitemid 47488225)
19. Bertolino A, Frye M, Callicott JH, Mattay VS, et al. (2003). Neuronal pathology in the hippocampal area of patients with bipolar disorder: a study with proton magnetic resonance spectroscopic imaging. Biological Psychiatry 53, 906-913. (Pubitemid 36556176)
20. Bezchlibnyk YB, Sun X, Wang J, MacQueen GM, et al. (2007). Neuron somal size is decreased in the lateral amygdalar nucleus of subjects with bipolar disorder. Journal of Psychiatry & Neuroscience 32, 203-210. (Pubitemid 46903861)
21. Bielau H, Trübner K, Krell D, Agelink MW, et al. (2005). Volume deficits of subcortical nuclei in mood disorders: the postmortem study. European Archives of Psychiatry and Clinical Neuroscience 255, 401-412. (Pubitemid 43029829)
22. Bouras C, Kövari E, Hof PR, Riederer BM, et al. (2001). Previous cingulate cortex pathology in schizophrenia and bipolar disorder. Acta Neuropathologica 102, 373-379. (Pubitemid 32894708)
23. Bowley MP, Drevets WC, Ongür D, Price JL (2002). Low glial numbers in the amygdala in major depressive disorder. Biological Psychiatry 52, 404-412. (Pubitemid 35266731)
24. Brambilla P, Perez J, Barale F, Schettini G, et al. (2003). GABAergic dysfunction in mood disorders. Molecular Psychiatry 8, 721-737. (Pubitemid 36976430)
25. Brooks IIIrd JO, Hoblyn JC, Woodard SA, Rosen AC, et al. (2009). Corticolimbic metabolic dysregulation in euthymic older adults with bipolar disorder. Journal of Psychiatric Research 43, 497-502.
26. Burruss JW, Hurley RA, Taber KH, Rauch RA, et al. (2000). Functional neuroanatomy of the frontal lobe circuits. Radiology 214, 227-230. (Pubitemid 30019897)
27. Buttner N, Bhattacharyya S, Walsh J, Benes FM (2007). DNA fragmentation is increased in non-GABAergic neurons in bipolar disorder but not in schizophrenia. Schizophrenia Research 93, 33-41. (Pubitemid 46817926)
28. Byne W, Tatusov A, Yiannoulos G, Vong GS, et al. (2008). Effects of mental illness and aging in two thalamic nuclei. Schizophrenia Research 106, 172-181.
29. Chana G, Landau S, Beasley C, Everall IP, et al. (2003). Two-dimensional assessment of cytoarchitecture in the previous cingulate cortex in major depressive disorder, bipolar disorder, and schizophrenia: evidence for decreased neuronal somal size and increased neuronal density. Biological Psychiatry 53, 1086-1098. (Pubitemid 36695084)
30. Chana G, Landau S, Everall I, Cotter D (2008). Glial cell number and nuclear size in the mediodorsal thalamic nucleus (MDNT) in schizophrenia. Schizophrenia Research 102, 344-345.
31. Che Y, Wang JF, Shao L, Young T (2010). Oxidative damage to RNA but not DNA in the hippocampus of patients with major mental illness. Journal of Psychiatry & Neuroscience 35, 296-302.
32. Chen G, Zeng WZ, Yuan PX, Huang LD, et al. (1999). The mood-stabilizing agents lithium and valproate robustly increase the levels of the neuroprotective protein bcl-2 in the CNS. Journal of Neurochemistry 72, 879-882. (Pubitemid 29055256)
33. Cotter D, Landau S, Beasley C, Stevenson R, et al. (2002a). The density and spatial distribution of GABAergic neurons, labeled using calcium binding proteins, in the previous cingulate cortex in major depressive disorder, bipolar disorder, and schizophrenia. Biological Psychiatry 51, 377-386. (Pubitemid 34251175)
34. Cotter D, Mackay D, Chana G, Beasley C, et al. (2002b). Reduced neuronal size and glial cell density in area 9 of the dorsolateral prefrontal cortex in subjects with major depressive disorder. Cerebral Cortex 12, 386-394. (Pubitemid 34226063)
35. Cotter D, Mackay D, Landau S, Kerwin R, et al. (2001). Reduced glial cell density and neuronal size in the previous cingulate cortex in major depressive disorder. Archives of General Psychiatry 58, 545-553. (Pubitemid 32523734)
36. Daban C, Vieta E, Mackin P, Young AH (2005). Hypothalamic-pituitary- adrenal axis and bipolar disorder. Psychiatric Clinics of North America 28, 469-480.
37. Deicken RF, Pegues MP, Anzalone S, FeiwellR, et al. (2003). Lower concentration of hippocampal N-acetylaspartate in familial bipolar I disorder. American Journal of Psychiatry 160, 873-882. (Pubitemid 41079571)
38. Drevets WC, Price JL, Simpson JR, Todd RD, et al. (1997). Subgenual prefrontal cortex abnormalities in mood disorders. Nature 386, 824-827. (Pubitemid 27181254)
39. Everall IP, Harrison JP (2002). Methodological and stereological considerations in postmortem psychiatric research. In: Agam G, Everall IP, Belmaker RH (Eds), The Postmortem Brain in Psychiatric Research (pp. 21-36). Boston: Kluwer Academic.
40. Fountoulakis KN, Giannakopoulos P, Kövari E, Bouras C (2008). Assessing the role of cingulate cortex in bipolar disorder: neuropathological, structural and functional imaging data. Brain Research Reviews 59, 9-21.
41. Frazier JA, Chiu S, Breeze JL, Makris N, et al. (2005). Structural brain magnetic resonance imaging of limbic and thalamic volumes in pediatric bipolar disorder. American Journal of Psychiatry 162, 1256-1265. (Pubitemid 40905575)
42. Galluzzi L, Blomgren K, Kroemer G (2009). Mitochondrial membrane permeabilization in neuronal injury. Nature Reviews Neuroscience 10, 481-494.
43. Gergerlioglu HS, Savas HA, Bulbul F, Selek S, et al. (2007). Changes in nitric oxide level and superoxide dismutase activity during antimanic treatment. Progress in Neuro-Psychopharmacology & Biological Psychiatry 31, 697-702. (Pubitemid 46467046)
44. Geuna S (2000). Appreciating the difference between design-based and model-based sampling strategies in quantitative morphology of the nervous system. Journal of Comparative Neurology 427, 333-339.
45. Grinberg LT, Amaro Junior E, da Silva AV, da Silva RE, et al. (2009). Improved detection of incipient vascular changes by a biotechnological platform combining post mortem MRI in situ with neuropathology. Journal of the Neurological Sciences 283, 2-8.
46. Grundt IK, Nyland H (1994). Activation of cultured glial cells by amitriptyline and platelet activating factor. Toxicology in Vitro: an International Journal Published in Association with BIBRA 8, 1015-1020. (Pubitemid 24325761)
47. Hamidi M, Drevets WC, Price JL (2004). Glial reduction in amygdala in major depressive disorder is due to oligodendrocytes. Biological Psychiatry 55, 563-569. (Pubitemid 38315029)
48. Harrison PJ (2002). The neuropathology of primary mood disorder. Brain 125, 1428-1449. (Pubitemid 34755160)
49. Hayes TL, Cameron JL, Fernstrom JD, Lewis DA (1991). A comparative analysis of the distribution of prosomatostatin-derived peptides in human and monkey neocortex. Journal of Comparative Neurology 303, 584-599.
50. Hercher C, Parent M, Flores C, Canetti L, et al. (2009). Alcohol dependence-related increase of glial cell density in the anterior cingulated cortex of suicide completers. Journal of Psychiatry & Neuroscience 34, 281-288.
51. Kato T (2006). The role of mitochondrial dysfunction in bipolar disorder. Drug News & Perspectives 19, 597-602. (Pubitemid 46813846)
52. Kato T (2008). Molecular neurobiology of bipolar disorder: a disease of 'mood-stabilizing neurons'? Trends in Neurosciences 31, 495-503.
53. Kauer-Sant'Anna M, Kapczinski F, Andreazza AC, Bond DJ, et al. (2009). Brain-derived neurotrophic factor and inflammatory markers in patients with early-vs. late-stage bipolar disorder. International Journal of Neuropsychopharmacology 12, 447-458.
54. Kaur S, Sassi RB, Axelson D, Nicoletti M, et al. (2005). Cingulate cortex anatomical abnormalities in children and adolescents with bipolar disorder. American Journal of Psychiatry 162, 1637-1643. (Pubitemid 41318232)
55. Keener MT, Phillips ML (2007). Neuroimaging in bipolar disorder: a critical review of current findings. Current Psychiatry Reports 9, 512-520. (Pubitemid 350284943)
56. Kim HW, Rapoport SI, Rao JS (2010). Altered expression of apoptotic factors and synaptic markers in postmortem brain from bipolar disorder patients. Neurobiology of Disease 37, 596-603.
57. Kodama M, Fujioka T, Duman RS (2004). Chronic olanzapine or fluoxetine administration increases cell proliferation in hippocampus and prefrontal cortex of adult rat. Biological Psychiatry 56, 570-580. (Pubitemid 39336404)
58. Konradi C, Eaton M, Walsh J, Benes FM, et al. (2004). Molecular evidence for mitochondrial dysfunction in bipolar disorder. Archives of General Psychiatry 61, 300-308. (Pubitemid 38295832)
59. Koo MS, Levitt JJ, Salisbury DF, Nakamura M, et al. (2008). A cross-sectional and longitudinal magnetic resonance imaging study of cingulate gyrus gray matter volume abnormalities in first-episode schizophrenia and first-episode affective psychosis. Archives of General Psychiatry 65, 746-760. (Pubitemid 351957701)
60. Kroemer G, Galluzzi L, Vandenabeele P, Abrams J, et al. (2009). Classification of cell death: recommendations of the Nomenclature Committee on Cell Death 2009. Cell Death and Differentiation 16, 3-11.
61. Kugaya A, Sanacora G (2005). Beyond monoamines: glutamatergic function in mood disorders. CNS Spectrums 10, 808-819. (Pubitemid 41531934)
62. Kuloglu M, Ustundag B, Atmaca M, Canatan H, et al. (2002). Lipid peroxidation and antioxidant enzyme levels in patients with schizophrenia and bipolar disorder. Cell Biochemistry and Function 20, 171-175.
63. Kunz M, Gama CS, Andreazza AC, Salvador M, et al. (2008). Elevated serum superoxide dismutase and thiobarbituric acid reactive substances in different phases of bipolar disorder and in schizophrenia. Progress in Neuro-Psychopharmacology & Biological Psychiatry 32, 1677-1681.
64. Law AJ, Harrison PJ (2003). The distribution and morphology of prefrontal cortex pyramidal neurons identified using anti-neurofilament antibodies SMI32, N200 and FNP7. Normative data and a comparison in subjects with schizophrenia, bipolar disorder or major depression. Journal of Psychiatric Research 37, 487-499. (Pubitemid 37238942)
65. Liu L, Schulz SC, Lee S, Reutiman TJ, et al. (2007). Hippocampal CA1 pyramidal cell size is reduced in bipolar disorder. Cellular and Molecular Neurobiology 27, 351-358. (Pubitemid 46763882)
66. Machado-Vieira R, Andreazza AC, Viale CI, Zanatto V, et al. (2007). Oxidative stress parameters in unmedicated and treated bipolar subjects during initial manic episode: a possible role for lithium antioxidant effects. Neuroscience Letters 421, 33-36. (Pubitemid 46908861)
67. Miguel-Hidalgo JJ, Rajkowska G (2003). Comparison of prefrontal cell pathology between depression and alcohol dependence. Journal of Psychiatry Research 37, 411-420. (Pubitemid 36808814)
68. Miguel-Hidalgo JJ, Wei J, Andrew M, Overholser JC, et al. (2002). Glia pathology in the prefrontal cortex in alcohol dependence with and without depressive symptoms. Biological Psychiatry 52, 1121-1133. (Pubitemid 35477667)
69. Moffett JR, Ross B, Arun P, Madhavarao CN, et al. (2007). N-Acetylaspartate in the CNS: from neurodiagnostics to neurobiology. Progress in Neurobiology 81, 89-131. (Pubitemid 46282272)
70. Molina V, Sánchez J, Sanz J, Reig S, et al. (2007). Dorsolateral prefrontal N-acetyl-aspartate concentration in male patients with chronic schizophrenia and with chronic bipolar disorder. European Psychiatry: the Journal of the Association of European Psychiatrists 22, 505-512. (Pubitemid 350087653)
71. Moore GJ, Cortese BM, Glitz DA, Zajac-Benitez C, et al. (2009). A longitudinal study of the effects of lithium treatment on prefrontal and subgenual prefrontal gray matter volume in treatment-responsive bipolar disorder patients. Journal of Clinical Psychiatry 70, 699-705.
72. Müller MB, Lucassen PJ, Yassouridis A, Hoogendijk WJ, et al. (2001). Neither major depression nor glucocorticoid treatment affects the cellular integrity of the human hippocampus. European Journal of Neuroscience 14, 1603-1612. (Pubitemid 35478029)
73. Nonaka S, Hough CJ, Chuang DM (1998). Chronic lithium treatment robustly protects neurons in the central nervous system against excitotoxicity by inhibiting N-methyl-D-aspartate receptor-mediated calcium influx. Proceedings of the National Academy of Sciences USA 95, 2642-2647. (Pubitemid 28145996)
74. O'Donovan MC, Craddock NJ, Owen MJ (2009). Genetics of psychosis; insights from views across the genome. Human Genetics 126, 3-12.
75. Olvera RL, Caetano SC, Fonseca M, Nicoletti M, et al. (2007). Low levels of N-acetyl aspartate in the left dorsolateral prefrontal cortex of pediatric bipolar patients. Journal of Child and Adolescent Psychopharmacology 17, 461-473. (Pubitemid 47417774)
76. [Erratum in: Journal of Child and Adolescent Psychopharmacology 2007, 17, 899-900.]
77. Omata N, Murata T, Takamatsu S, Maruoka N, et al. (2008). Neuroprotective effect of chronic lithium treatment against hypoxia in specific brain regions with upregulation of cAMP response element binding protein and brain-derived neurotrophic factor but not nerve growth factor: comparison with acute lithium treatment. Bipolar Disorders 10, 360-368. (Pubitemid 351517370)
78. Ongür D, Drevets WC, Price JL (1998). Glial reduction in the subgenual prefrontal cortex in mood disorders. Proceedings of the National Academy of Sciences USA 95, 13290-13295. (Pubitemid 28509564)
79. Orrenius S (2007). Reactive oxygen species in mitochondria-mediated cell death. Drug Metabolism Reviews 39, 443-455. (Pubitemid 47355728)
80. Ott M, Gogvadze V, Orrenius S, Zhivotovsky B (2007). Mitochondria, oxidative stress and cell death. Apoptosis 12, 913-922. (Pubitemid 46653300)
81. Palomino A, Vallejo-Illarramendi A, González-Pinto A, Aldama A, et al. (2006). Decreased levels of plasma BDNF in first-episode schizophrenia and bipolar disorder patients. Schizophrenia Research 86, 321-322. (Pubitemid 44234056)
82. Pfeifer JC, Welge J, Strakowski SM, Adler CM, et al. (2008). Meta-analysis of amygdala volumes in children and adolescents with bipolar disorder. Journal of the American Academy of Child and Adolescent Psychiatry 47, 1289-1298.
83. Rajkowska G (2002). Cell pathology bipolar in disorder. Bipolar Disorders 4, 105-116.
84. Rajkowska G, Halaris A, Selemon LD (2001). Reductions in neuronal and glial density characterize the dorsolateral prefrontal cortex in bipolar disorder. Biological Psychiatry 49, 741-752. (Pubitemid 32452295)
85. Rajkowska G, Miguel-Hidalgo JJ, Dubey P, Stockmeier CA, et al. (2005). Prominent reduction in pyramidal neurons density in the orbitofrontal cortex of elderly depressed patients. Biological Psychiatry 58, 297-306. (Pubitemid 41133623)
86. Ranjekar PK, Hinge A, Hegde MV, Ghate M, et al. (2003). Decreased antioxidant enzymes and membrane essential polyunsaturated fatty acids in schizophrenic and bipolar mood disorder patients. Psychiatry Research 121, 109-122. (Pubitemid 37500981)
87. Rao JS, Harry GJ, Rapoport SI, Kim HW (2010). Increased excitotoxicity and neuroinflammatory markers in postmortem frontal cortex from bipolar disorder patients. Molecular Psychiatry 15, 384-392.
88. Rowe MK, Chuang DM (2004). Lithium neuroprotection: molecular mechanisms and clinical implications. Expert Reviews in Molecular Medicine 6, 1-18.
89. Rutten BP, Mill J (2009). Epigenetic mediation of environmental influences in major psychotic disorders. Schizophrenia Bulletin 35, 1045-1056.
90. Sakai T, Oshima A, Nozaki Y, Ida I, et al. (2008). Changes in density of calcium-binding-protein-immunoreactive GABAergic neurons in prefrontal cortex in schizophrenia and bipolar disorder. Neuropathology 28, 143-150. (Pubitemid 351441698)
91. Sanacora G (2008). New understanding of mechanisms of action of bipolar medications. Journal of Clinical Psychiatry 69 (Suppl.), 22-27.
92. Sassi RB, Stanley JA, Axelson D, Brambilla P, et al. (2005). Reduced NAA levels in the dorsolateral prefrontal cortex of young bipolar patients. American Journal of Psychiatry 162, 2109-2115. (Pubitemid 41598265)
93. Scherk H, Backens M, Schneider-Axmann T, Kemmer C, et al. (2008). Neurochemical pathology in hippocampus in euthymic patients with bipolar I disorder. Acta Psychiatrica Scandinavica 117, 283-288. (Pubitemid 351347464)
94. Schloesser RJ, Huang J, Klein PS, Manji HK (2008). Cellular plasticity cascades in the pathophysiology and treatment of bipolar disorder. Neuropsychopharmacology 33, 110-133. (Pubitemid 350191320)
95. Schmitz C, Hof PR (2005). Design-based stereology in neuroscience. Neuroscience 130, 813-831. (Pubitemid 40094616)
96. Selek S, Savas HA, Gergerlioglu HS, Bulbul F, et al. (2008). The course of nitric oxide and superoxide dismutase during treatment of bipolar depressive episode. Journal of Affective Disorders 107, 89-94. (Pubitemid 351288914)
97. Selemon LD, Lidow MS, Goldman-Rakic PS (1999). Increased volume and glial density in primate prefrontal cortex associated with chronic antipsychotic drug exposure. Biological Psychiatry 46, 161-172. (Pubitemid 29320067)
98. Stork C, Renshaw PF (2005). Mitochondrial dysfunction in bipolar disorder: evidence from magnetic resonance spectroscopy research. Molecular Psychiatry 10, 900-919. (Pubitemid 41486483)
99. Sun X, Wang JF, Tseng M, Young LT (2006). Downregulation in components of the mitochondrial electron transport chain in the postmortem frontal cortex of subjects with bipolar disorder. Journal of Psychiatry & Neuroscience 31, 189-196. (Pubitemid 43954738)
100. Teipel SJ, Meindl T, Grinberg L, Heinsen H, et al. (2008). Novel MRI techniques in the assessment of dementia. European Journal of Nuclear Medicine and Molecular Imaging 35 (Suppl.), 58-69.
101. Uranova N, Orlovskaya D, Vikhreva A, Zimina I, et al. (2001). Electron microscopy of oligodendroglia in severe mental illness. Brain Research Bulletin 55, 597-610. (Pubitemid 32888378)
102. Uranova N, Vostrikov VM, Orlovskaya DD, Rachmanova VI (2004). Oligodendroglial density in the prefrontal cortex in schizophrenia and mood disorders: the study from the Stanley Neuropathology Consortium. Schizophrenia Research 67, 269-275. (Pubitemid 38251458)
103. Vostrikov VM, Uranova N, Orlovskaya DD (2007). Deficit of perineuronal oligodendrocytes in the prefrontal cortex in schizophrenia and mood disorders. Schizophrenia Research 94, 273-280. (Pubitemid 47031593)
104. Wang JF (2007). Defects of mitochondrial electron transport chain in bipolar disorder: implications for mood-stabilizing treatment. Canadian Journal of Psychiatry 52, 753-762.
105. Wang JF, Azzam JE, Young LT (2003). Valproate inhibits oxidative damage to lipid and protein in primary cultured rat cerebrocortical cells. Neuroscience 116, 485-489. (Pubitemid 36139918)
106. Wang JF, Shao L, Sun X, Young LT (2009). Increased oxidative stress in the anterior cingulate cortex of subjects with bipolar disorder and schizophrenia. Bipolar Disorders 11, 523-529.
107. Winsberg ME, Sachs N, Tate DL, Adalsteinsson E, et al. (2000). Decreased dorsolateral prefrontal N-acetyl aspartate in bipolar disorder. Biological Psychiatry 47, 475-481. (Pubitemid 30129075)
108. Woo TU, Walsh JP, Benes FM (2004). Density of glutamic acid decarboxylase 67 messenger RNA-containing neurons that express the N-methyl-D-aspartate receptor subunit NR2A in the anterior cingulate cortex in schizophrenia and bipolar disorder. Archives of General Psychiatry 61, 649-657. (Pubitemid 38890797)
109. Yatham LN (2005). Translating knowledge of genetics and pharmacology into improving everyday practice. Bipolar Disorders 7 (Suppl.), 13-20. (Pubitemid 41065245)
110. Yatham LN, Kapczinski F, Andreazza AC, Trevor Young L, et al. (2009). Accelerated age-related decrease in brain-derived neurotrophic factor levels in bipolar disorder. International Journal of Neuropsychopharmacology 12, 137-139.
111. Yeste M, Alvira D, Verdaguer E, Tajes M, et al. (2007). Evaluation of acute antiapoptotic effects of Li+ in neuronal cell cultures. Journal of Neural Transmission 114, 405-416. (Pubitemid 46474862)
112. Young KA, Holcomb LA, Bonkale WL, Hicks PB, et al. (2007). 5HTTLPR polymorphism and enlargement of the pulvinar: unlocking the backdoor to the limbic system. Biological Psychiatry 61, 813-818. (Pubitemid 46330249)
113. Young KA, Holcomb LA, Yazdani U, Hicks PB, et al. (2004). Elevated neuron number in the limbic thalamus in major depression. American Journal of Psychiatry 161, 1270-1277. (Pubitemid 38859178)
114. Young LT (2001). Postreceptor pathways for signal transduction in depression and bipolar disorder. Journal of Psychiatry & Neuroscience 26, S17-S22. (Pubitemid 34218790)
115. Young LT, Bakish D, Beaulieu S (2002). The neurobiology of treatment response to antidepressants and mood stabilizing medications. Journal of Psychiatry & Neuroscience 27, 260-265. (Pubitemid 34988906)
116. Yucel K, McKinnon MC, Taylor VH, Macdonald K, et al. (2007). Bilateral hippocampal volume increases after long-term lithium treatment in patients with bipolar disorder: a longitudinal MRI study. Psychopharmacology 195, 357-367. (Pubitemid 350160270)
117. Yucel K, Taylor VH, McKinnon MC, Macdonald K, et al. (2008). Bilateral hippocampal volume increase in patients with bipolar disorder and short-term lithium treatment. Neuropsychopharmacology 33, 361-367. (Pubitemid 350243347)
118. Zhong J, Yang X, Yao W, Lee W (2006). Lithium protects ethanol-induced neuronal apoptosis. Biochemical and Biophysical Research Communications 350, 905-910. (Pubitemid 44596222)